PG
IBM icon

Prostatis Group’s IBM IBM Stock Holding History

Prostatis Group’s Portfolio IBM Stock Details IBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Sell
1,076
-1,451
-57% -$366K 0.07% 142
2026
Q1 		$612K Buy
2,527
+376
+17% +$102K 0.16% 96
2025
Q4 		$637K Buy
2,151
+1,147
+114% +$344K 0.15% 91
2025
Q3 		$283K Sell
1,004
-424
-30% -$111K 0.07% 136
2025
Q2 		$421K Sell
1,428
-318
-18% -$81.9K 0.12% 104
2025
Q1 		$434K Sell
1,746
-119
-6% -$29.1K 0.14% 99
2024
Q4 		$410K Sell
1,865
-86
-4% -$19.2K 0.12% 113
2024
Q3 		$431K Buy
1,951
+317
+19% +$62.2K 0.14% 100
2024
Q2 		$283K Buy
1,634
+119
+8% +$20.7K 0.1% 120
2024
Q1 		$289K Buy
1,515
+273
+22% +$49.8K 0.11% 117
2023
Q4 		$203K Sell
1,242
-5,494
-82% -$830K 0.08% 127
2023
Q3 		$934K Buy
6,736
+73
+1% +$10.4K 0.46% 46
2023
Q2 		$892K Sell
6,663
-619
-9% -$79.9K 0.41% 54
2023
Q1 		$951K Sell
7,282
-169
-2% -$22.6K 0.5% 50
2022
Q4 		$1.05M Buy
+7,451
New +$1.03M 0.64% 41

Other funds holding IBM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prostatis Group's IBM Position: Q2 2026 in Review

Prostatis Group reduced its IBM (IBM) stake by 57% in Q2 2026, selling an estimated $366K and leaving 1,076 shares worth $302K. The position accounts for 0.07% of the portfolio, ranked #142.

Prostatis Group first reported a position in IBM in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.05M in Q4 2022. 3,643 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Prostatis Group held 1,076 shares of IBM worth $302K as of Q2 2026.
  • Prostatis Group sold 1,451 IBM shares in Q2 2026, an estimated $366K.
  • IBM made up 0.07% of Prostatis Group's portfolio in Q2 2026, its #142 holding.
  • Prostatis Group first reported a position in IBM in Q4 2022 and has held it in 15 quarters since.
  • Prostatis Group's IBM position peaked at $1.05M in Q4 2022.
  • 3,643 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.